|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-3-10
|
|
pubmed:abstractText |
Quinidine is very effective in preventing the reinduction of sustained ventricular fibrillation (VF) during electrophysiologic study (EPS) in patients with idiopathic VF and Brugada syndrome. However, there are no data on the long-term reproducibility of this EP efficacy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1540-8159
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
294-301
|
|
pubmed:meshHeading |
pubmed-meshheading:19272057-Adult,
pubmed-meshheading:19272057-Aged,
pubmed-meshheading:19272057-Anti-Arrhythmia Agents,
pubmed-meshheading:19272057-Brugada Syndrome,
pubmed-meshheading:19272057-Clinical Trials as Topic,
pubmed-meshheading:19272057-Electrocardiography,
pubmed-meshheading:19272057-Female,
pubmed-meshheading:19272057-Humans,
pubmed-meshheading:19272057-Longitudinal Studies,
pubmed-meshheading:19272057-Male,
pubmed-meshheading:19272057-Middle Aged,
pubmed-meshheading:19272057-Quinidine,
pubmed-meshheading:19272057-Reproducibility of Results,
pubmed-meshheading:19272057-Sensitivity and Specificity,
pubmed-meshheading:19272057-Treatment Outcome,
pubmed-meshheading:19272057-Ventricular Fibrillation,
pubmed-meshheading:19272057-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
|
|
pubmed:affiliation |
Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. bblhass@tasmc.health.gov.il
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
